Real-time enrollment status for this heart failure clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:27 PM UTC
| NCT Number | NCT06307652 |
| Recruiting Status | Recruiting |
| Condition | Heart Failure |
| Phase | PHASE3 |
| Target Enrollment | 4,800 participants |
| Active Locations | 166 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | June 26, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT06307652 is currently recruiting participants. This phase3 study for heart failure is actively seeking new participants at 166 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06307652 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 166 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06307652 was last updated 3 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.